Multidisciplinary background in cell biology, immunology, and biomolecular engineering. Accomplished Staff Scientist demonstrating strong knowledge of various scientific methods and techniques, assay development and research skills. Experienced in project management, proposal writing and presentation. Highly organized, proactive and punctual with team-oriented mentality.
|
|
Thesis: Preliminary Steps to Isolate a Novel Receptor for Mac-1.
1. Langowski, M. D., Khan, F. A., Bitzer, A. A., Genito, C. J., Schrader, A. J., Martin, M. L., Soto, K., Zou, X., Hadiwidjojo, S., Beck, Z., Matyas, G. R., Livingstone, M. C., Batchelor, A. H., and Dutta, S. (2020) Optimization of a Plasmodium falciparum circumsporozoite protein repeat vaccine using the tobacco mosaic virus platform. Proc Natl Acad Sci U S A 117, 3114-3122
2. Winer, B., Edgel, K. A., Zou, X., Sellau, J., Hadiwidjojo, S., Garver, L. S., McDonough, C. E., Kelleher, N. L., Thomas, P. M., Villasante, E., Ploss, A., and Gerbasi, V. R. (2020) Identification of Plasmodium falciparum proteoforms from liver stage models. Malar J 19, 10
3. Martin, M. L., Bitzer, A. A., Schrader, A., Bergmann-Leitner, E. S., Soto, K., Zou, X., Beck, Z., Matyas, G. R., and Dutta, S. (2019) Comparison of immunogenicity and safety outcomes of a malaria vaccine FMP013/ALFQ in rhesus macaques (Macaca mulatta) of Indian and Chinese origin. Malar J 18, 377
4. Cawlfield, A., Genito, C. J., Beck, Z., Bergmann-Leitner, E. S., Bitzer, A. A., Soto, K., Zou, X., Hadiwidjojo, S. H., Gerbasi, R. V., Mullins, A. B., Noe, A., Waters, N. C., Alving, C. R., Matyas, G. R., and Dutta, S. (2019) Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ). Vaccine 37, 3793-3803
5. Zou, X., House, B. L., Zyzak, M. D., Richie, T. L., and Gerbasi, V. R. (2013) Towards an optimized inhibition of liver stage development assay (ILSDA) for Plasmodium falciparum. Malar J 12, 394
6. McCoy, M. E., Golden, H. E., Doll, T. A., Yang, Y., Kaba, S. A., Zou, X., Gerbasi, V. R., Burkhard, P., and Lanar, D. E. (2013) Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine. Malar J 12, 136
7. Plassmeyer, M. L., Reiter, K., Shimp, R. L., Jr., Kotova, S., Smith, P. D., Hurt, D. E., House, B., Zou, X., Zhang, Y., Hickman, M., Uchime, O., Herrera, R., Nguyen, V., Glen, J., Lebowitz, J., Jin, A. J., Miller, L. H., MacDonald, N. J., Wu, Y., and Narum, D. L. (2009) Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate. J Biol Chem 284, 26951-26963
8. Zou, X., Shinde Patil, V. R., Dagia, N. M., Smith, L. A., Wargo, M. J., Interliggi, K. A., Lloyd, C. M., Tees, D. F., Walcheck, B., Lawrence, M. B., and Goetz, D. J. (2005) PSGL-1 derived from human neutrophils is a high-efficiency ligand for endothelium-expressed E- selectin under flow. Am J Physiol Cell Physiol 289, C415-424
9. Sundd, P., Zou, X., Goetz, D. J., and Tees, D. F. (2008) Leukocyte adhesion in capillary- sized, P-selectin-coated micropipettes. Microcirculation 15, 109-122
Resumes, and other information uploaded or provided by the user, are considered User Content governed by our Terms & Conditions. As such, it is not owned by us, and it is the user who retains ownership over such content.
Companies Worked For:
School Attended
Job Titles Held:
Degrees
